OpenURL Connection Search

Select item for more details and to access through your institution.

Tumour necrosis as assessed with <sup>18</sup>F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements.
Published in:
2019
By:
- Kahle, Xaver U.;
- Hovingh, Menno;
- Noordzij, Walter;
- Seitz, Annika;
- Diepstra, Arjan;
- Visser, Lydia;
- van den Berg, Anke;
- van Meerten, Tom;
- Huls, Gerwin;
- Boellaard, Ronald;
- Kwee, Thomas C.;
- Nijland, Marcel
Publication type:
journal article
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01022-w
By:
- Keijzer, Kylie;
- de Boer, Janneke W.;
- van Doesum, Jaap A.;
- Noordzij, Walter;
- Huls, Gerwin A.;
- van Dijk, Lisanne V.;
- van Meerten, Tom;
- Niezink, Anne G. H.
Publication type:
Article
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties.
Published in:
Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00007-0
By:
- Vlaming, Martijn;
- Bilemjian, Vrouyr;
- Freile, Jimena Álvarez;
- Lourens, Harm Jan;
- van Rooij, Nienke;
- Huls, Gerwin;
- van Meerten, Tom;
- de Bruyn, Marco;
- Bremer, Edwin
Publication type:
Article
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13751, doi. 10.3390/ijms232213751
By:
- Langendonk, Myra;
- Smit, Nienke A. M.;
- Plattel, Wouter;
- Diepstra, Arjan;
- Meerten, Tom van;
- Visser, Lydia
Publication type:
Article
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
Published in:
International Journal of Molecular Sciences, 2019, v. 20, n. 23, p. 6036, doi. 10.3390/ijms20236036
By:
- de Jong, Mathilde Rikje Willemijn;
- Langendonk, Myra;
- Reitsma, Bart;
- Nijland, Marcel;
- van den Berg, Anke;
- Ammatuna, Emanuele;
- Visser, Lydia;
- van Meerten, Tom
Publication type:
Article
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
Published in:
British Journal of Haematology, 2021, v. 195, n. 3, p. 388, doi. 10.1111/bjh.17673
By:
- Topp, Max S.;
- van Meerten, Tom;
- Houot, Roch;
- Minnema, Monique C.;
- Bouabdallah, Krimo;
- Lugtenburg, Pieternella J.;
- Thieblemont, Catherine;
- Wermke, Martin;
- Song, Kevin W.;
- Avivi, Irit;
- Kuruvilla, John;
- Dührsen, Ulrich;
- Zheng, Yan;
- Vardhanabhuti, Saran;
- Dong, Jinghui;
- Bot, Adrian;
- Rossi, John M.;
- Plaks, Vicki;
- Sherman, Marika;
- Kim, Jenny J.
Publication type:
Article
High frequency of hyperglycaemia observed during CAR T‐cell treatment.
Published in:
Diabetic Medicine, 2023, v. 40, n. 2, p. 1, doi. 10.1111/dme.14969
By:
- Tienstra, Marieke;
- de Boer, Janneke W.;
- van Doesum, Jaap A.;
- van Meerten, Tom;
- van Dijk, Peter R.
Publication type:
Article
Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma.
Published in:
2018
By:
- Nijland, Marcel;
- van Meerten, Tom;
- Huls, Gerwin;
- Seitz, Annika;
- Visser, Lydia;
- van den Berg, Anke;
- Diepstra, Arjan;
- Kibbelaar, Robby
Publication type:
Case Study
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis.
Published in:
Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08013-z
By:
- He, Yuan;
- Bouwstra, Renee;
- Wiersma, Valerie R.;
- de Jong, Mathilde;
- Jan Lourens, Harm;
- Fehrmann, Rudolf;
- de Bruyn, Marco;
- Ammatuna, Emanuele;
- Huls, Gerwin;
- van Meerten, Tom;
- Bremer, Edwin
Publication type:
Article
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Published in:
Cancers, 2023, v. 15, n. 22, p. 5443, doi. 10.3390/cancers15225443
By:
- de Boer, Janneke W.;
- Keijzer, Kylie;
- Pennings, Elise R. A.;
- van Doesum, Jaap A.;
- Spanjaart, Anne M.;
- Jak, Margot;
- Mutsaers, Pim G. N. J.;
- van Dorp, Suzanne;
- Vermaat, Joost S. P.;
- van der Poel, Marjolein W. M.;
- van Dijk, Lisanne V.;
- Kersten, Marie José;
- Niezink, Anne G. H.;
- van Meerten, Tom
Publication type:
Article
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Published in:
Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
By:
- Spanjaart, Anne M.;
- Pennings, Elise R. A.;
- Mutsaers, Pim G. N. J.;
- van Dorp, Suzanne;
- Jak, Margot;
- van Doesum, Jaap A.;
- de Boer, Janneke W.;
- Niezink, Anne G. H.;
- Kos, Milan;
- Vermaat, Joost S. P.;
- Sijs-Szabo, Aniko;
- van der Poel, Marjolein W. M.;
- Nijhof, Inger S.;
- Kuipers, Maria T.;
- Chamuleau, Martine E. D.;
- Lugtenburg, Pieternella J.;
- Doorduijn, Jeanette K.;
- Serroukh, Yasmina I. M.;
- Minnema, Monique C.;
- van Meerten, Tom
Publication type:
Article
The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity.
Published in:
Cancers, 2022, v. 14, n. 2, p. 299, doi. 10.3390/cancers14020299
By:
- He, Yuan;
- Vlaming, Martijn;
- van Meerten, Tom;
- Bremer, Edwin
Publication type:
Article
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage.
Published in:
Cancers, 2019, v. 11, n. 11, p. 1743, doi. 10.3390/cancers11111743
By:
- de Jong, Mathilde Rikje Willemijn;
- Langendonk, Myra;
- Reitsma, Bart;
- Herbers, Pien;
- Nijland, Marcel;
- Huls, Gerwin;
- van den Berg, Anke;
- Ammatuna, Emanuele;
- Visser, Lydia;
- van Meerten, Tom
Publication type:
Article
Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.
Published in:
Cancers, 2018, v. 10, n. 11, p. 459, doi. 10.3390/cancers10110459
By:
- Nijland, Marcel;
- Seitz, Annika;
- Terpstra, Martijn;
- van Imhoff, Gustaaf W.;
- Kluin, Philip M;
- van Meerten, Tom;
- Atayar, Çiğdem;
- van Kempen, Léon C.;
- Diepstra, Arjan;
- Kok, Klaas;
- van den Berg, Anke
Publication type:
Article
CD47‐SIRPα blocking‐based immunotherapy: Current and prospective therapeutic strategies.
Published in:
Clinical & Translational Medicine, 2022, v. 12, n. 8, p. 1, doi. 10.1002/ctm2.943
By:
- Bouwstra, Renée;
- van Meerten, Tom;
- Bremer, Edwin
Publication type:
Article
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma.
Published in:
Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620719898373
By:
- de Jong, Mathilde R. W.;
- Langendonk, Myra;
- Reitsma, Bart;
- Herbers, Pien;
- Lodewijk, Monique;
- Nijland, Marcel;
- van den Berg, Anke;
- Ammatuna, Emanuele;
- Visser, Lydia;
- van Meerten, Tom
Publication type:
Article
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00723-4
By:
- Al-Sarayfi, Diana;
- Meeuwes, Frederik O.;
- Durmaz, Müjde;
- Issa, Djamila E.;
- Brouwer, Rolf E.;
- Beeker, Aart;
- van Rhenen, Anna;
- Mutsaers, Pim G. N. J.;
- Böhmer, Lara H.;
- van der Poel, Marjolein W. M.;
- te Boome, Liane;
- van Meerten, Tom;
- Chamuleau, Martine E. D.;
- Zijlstra, Josée M.;
- Brink, Mirian;
- Nijland, Marcel
Publication type:
Article
Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00631-7
By:
- Langendonk, Myra;
- de Jong, Mathilde R. W.;
- Smit, Nienke;
- Seiler, Jonas;
- Reitsma, Bart;
- Ammatuna, Emanuele;
- Glaudemans, Andor W. J. M.;
- van den Berg, Anke;
- Huls, Gerwin A.;
- Visser, Lydia;
- van Meerten, Tom
Publication type:
Article
428. Development of an Effective Safety Switch for Selective Elimination of Human T Cells In Vivo after Adoptive Transfer.
Published in:
Molecular Therapy, 2006, v. 13, p. S164, doi. 10.1016/j.ymthe.2006.08.493
By:
- van Meerten, Tom;
- Rozemuller, Henk;
- Mackus, Wendy;
- Parren, Paul;
- van de Winkel, Jan;
- Claessen, Marie-Jose;
- van Rijn, Rozemarijn;
- Hagenbeek, Anton;
- Martens, Anton;
- Ebeling, Saskia
Publication type:
Article
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma.
Published in:
Biomedicines, 2022, v. 10, n. 5, p. 1175, doi. 10.3390/biomedicines10051175
By:
- Freile, Jimena Álvarez;
- Ustyanovska Avtenyuk, Natasha;
- Corrales, Macarena González;
- Lourens, Harm Jan;
- Huls, Gerwin;
- van Meerten, Tom;
- Cendrowicz, Ewa;
- Bremer, Edwin
Publication type:
Article
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma.
Published in:
American Journal of Cancer Research, 2024, v. 14, n. 6, p. 2905, doi. 10.62347/LLXR8002
By:
- van Meerten, Tom;
- Kuruvilla, John;
- Song, Kevin W.;
- Thieblemont, Catherine;
- Minnema, Monique C.;
- Forcade, Edouard;
- De Guibert, Sophie;
- Kersten, Marie José;
- Mutsaers, Pim GNJ;
- Wermke, Martin;
- Yan Zheng;
- Xue, Allen;
- Winters, Joshua N.;
- Nater, Jenny;
- Shen, Rhine R.;
- Spooner, Clare;
- Neumann, Frank;
- Kim, Jenny J.;
- Topp, Max S.
Publication type:
Article
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.
Published in:
Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00501-x
By:
- Lin, Yusheng;
- Choukrani, Ghizlane;
- Dubbel, Lena;
- Rockstein, Lena;
- Freile, Jimena Alvarez;
- Qi, Yuzhu;
- Wiersma, Valerie;
- Zhang, Hao;
- Koch, Karl-Wilhelm;
- Ammatuna, Emanuele;
- Schuringa, Jan Jacob;
- van Meerten, Tom;
- Huls, Gerwin;
- Bremer, Edwin
Publication type:
Article
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02256-x
By:
- Cendrowicz, Ewa;
- Jacob, Lisa;
- Greenwald, Shirley;
- Tamir, Ami;
- Pecker, Iris;
- Tabakman, Rinat;
- Ghantous, Lucy;
- Tamir, Liat;
- Kahn, Roy;
- Avichzer, Jasmine;
- Aronin, Alexandra;
- Amsili, Shira;
- Zorde-Khvalevsky, Elina;
- Gozlan, Yosi;
- Vlaming, Martijn;
- Huls, Gerwin;
- van Meerten, Tom;
- Dranitzki, Michal Elhalel;
- Foley-Comer, Adam;
- Pereg, Yaron
Publication type:
Article
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.
Published in:
PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193098
By:
- de Jong, Mathilde R. W.;
- Visser, Lydia;
- Huls, Gerwin;
- Diepstra, Arjan;
- van Vugt, Marcel;
- Ammatuna, Emanuele;
- van Rijn, Rozemarijn S.;
- Vellenga, Edo;
- van den Berg, Anke;
- Fehrmann, Rudolf S. N.;
- van Meerten, Tom
Publication type:
Article

Found: 24